ClinicalTrials.Veeva

Menu

Erbium-YAG Laser Versus Platelet Rich Plasma in the Treatment of Atrophic Acne Scars

A

Aswan University Hospital

Status

Completed

Conditions

Scars
Acne Vulgaris

Treatments

Procedure: Platelet Rich Plasma
Device: Fractional Erbium Yağ Laser

Study type

Interventional

Funder types

Other

Identifiers

NCT03933033
Erbium Yag

Details and patient eligibility

About

This study aim to assess the efficacy of Er-YAG laser 2940nm and PRP as a single line of treatment in comparison with combined treatment in atrophic post acne scars.

Enrollment

75 patients

Sex

All

Ages

18 to 38 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with atrophic post acne scars classified on the basis of Goodman and Baron's Qualitative classification, no active acne lesions and patients with atrophic scars only

Exclusion criteria

  • patients with positive history of keloidal tendency, positive history of bleeding tendency, platelet disorder, patients with any acute infection on face like, herpes, folliculitis, patients with HIV, HBsAg, patients with a history of autoimmune diseases or patients on immunosuppressive drugs.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

75 participants in 3 patient groups

Group A
Active Comparator group
Description:
treated with platelet rich plasma
Treatment:
Procedure: Platelet Rich Plasma
Group B
Active Comparator group
Description:
treated with Erbium Yag Laser
Treatment:
Device: Fractional Erbium Yağ Laser
Group C
Active Comparator group
Description:
treated with both line of treatments
Treatment:
Procedure: Platelet Rich Plasma
Device: Fractional Erbium Yağ Laser

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems